Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
654 |
|
Actual shortage: | 15 (2%) | |
Anticipated shortage: | 7 (1%) | |
Avoided shortage: | 85 (13%) | |
Resolved: | 547 (84%) | |
Discontinuation Reports |
234 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 234 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Resolved | 2022-08-03 | 2022-10-05 | 166034 |
MYLAN-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-08-03 | 2023-10-03 | 166037 |
MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-09-01 | 2022-09-07 | 168381 |
MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2022-09-01 | 2023-02-06 | 168386 |
FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171501 |
FREYA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171506 |
MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-10-19 | 2023-01-10 | 172186 |
MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Resolved | 2022-10-25 | 2022-11-22 | 172533 |
MYLAN-ATOVAQUONE/PROGUANIL | 100MG 250MG | TABLET | Resolved | 2022-10-25 | 2023-01-17 | 172537 |
MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2022-11-17 | 2023-09-06 | 175112 |
MYLAN-SUMATRIPTAN | 50MG | TABLET | Resolved | 2022-11-22 | 2023-01-10 | 175406 |
MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2022-11-29 | 2023-01-17 | 176221 |
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-01-10 | 2023-03-20 | 180346 |
MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-01-10 | 2023-02-14 | 180349 |
MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2023-01-17 | 2023-05-25 | 181289 |
INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
MYLAN-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-01-17 | 2023-01-23 | 181324 |
MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Resolved | 2023-01-18 | 2024-05-08 | 181369 |
MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-01-23 | 2023-07-14 | 182205 |
MYLAN-ACYCLOVIR | 200MG | TABLET | Resolved | 2023-02-01 | 2023-03-20 | 182969 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |